Friday, 27 Mar 2020

You are here

Week in Review - 20 Feb 2016

  1. Dr. Jeff Curtis: blog on why  some patients don't/won't do T2T and how to best frame the need for T2T in RA
  2. Poor outcomes in spondyloarthritis  due to: age >33yr, low education level, smoking, high baseline BASDAI and not meeting ASAS criteria
  3. IL-36 is an important mediator of bowel inflammation in mouse model of IBD, Blocking IL-36 improves the IBD
  4. Opioid Use Increases the Risk of Hospitalized Infections in RA.
  5. Myelodysplasia is associated with a  29% risk of developing autoimmune disease. Most common are: hypothyroid, ITP, RA, psoriasis.  Better survival, less AML transformation when autoimmune disease is present.
  6.  21% of spondyloarthritis patients have secondary fibromyalgia (and only 30% of these were women). FM-SpA patients, not surprisingly, had more depression, psychotropics, opioid use
  7. Hidradenitis suppurativa is associated with higher rates of cardiovascular events and all-cause mortality.
  8. Increasing Ultrasound training is provided in 90% of US Rheumatology Fellowships
  9. Review of lectures at – Check out


The author has no conflicts of interest to disclose related to this subject
Dr. Cush is the Director of Clinical Rheumatology at the Baylor Research Institute and a Professor of Medicine and Rheumatology at Baylor University Medical Center in Dallas, TX. He a Professor of Clinical Medicine at the University of Texas Southwestern Medical School.
Dr. Cush is the Executive Editor of and also Co-Edits the online textbook 
Dr. Cush's research and interests include novel drug development, rheumatoid arthritis, spondyloarthritis, drug safety, pregnancy and Still's disease/autoinflammatory syndromes. He has published over 140 articles and 2 books in rheumatology.
He can be followed on twitter: @RheumNow.

Add new comment